Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

12 trials with published results (7%)

Research Maturity

95 completed trials (56% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.6%

6 terminated out of 169 trials

Success Rate

94.1%

+7.5% vs benchmark

Late-Stage Pipeline

7%

12 trials in Phase 3/4

Results Transparency

13%

12 of 95 completed with results

Key Signals

12 with results94% success

Data Visualizations

Phase Distribution

94Total
Not Applicable (34)
Early P 1 (6)
P 1 (17)
P 2 (25)
P 3 (9)
P 4 (3)

Trial Status

Completed95
Unknown30
Recruiting12
Active Not Recruiting10
Withdrawn8
Not Yet Recruiting6

Trial Success Rate

94.1%

Benchmark: 86.6%

Based on 95 completed trials

Clinical Trials (169)

Showing 20 of 20 trials
NCT07703475Phase 1Not Yet RecruitingPrimary

A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine

NCT07845396Completed

Assessment of Stress and Associated Factors Among Young Adults During the COVID-19 Pandemic

NCT07739446Not ApplicableEnrolling By Invitation

Effect of Surgical Masks in Preventing Acute Respiratory Infections

NCT04359836Suspended

A Study to Explore the Role of Gut Flora in COVID-19 Infection

NCT07816471Active Not Recruiting

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

NCT07287137Phase 4Active Not Recruiting

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

NCT07445971Phase 1RecruitingPrimary

A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.

NCT06698549Phase 1CompletedPrimary

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

NCT07030075Recruiting

Surveillance, Assessment and Detection of Influenza Associated Respiratory Infections in HIV Positive and Negative Individual in Lusaka, Zambia.

NCT04743401Not ApplicableCompletedPrimary

Feasibility of a Tele-game-based Exercise (Tele-exergame) Program to Prevent Deconditioning in Hospitalized COVID-19 Patients

NCT07599449Recruiting

Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

NCT07728396Phase 1Active Not RecruitingPrimary

A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults

NCT07416539Phase 1Active Not RecruitingPrimary

Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19

NCT07711444Not ApplicableCompletedPrimary

The Efficacy of Long-Chain Fatty Acids, Eicosapentaenoic Acid (EPA) and Specialized Pro-Resolving Mediators (SPMs), in Treating Long COVID Neuropsychiatric Symptoms

NCT06907251Phase 3Not Yet RecruitingPrimary

Dapagliflozin for Long COVID Syndrome

NCT04354558Active Not Recruiting

French Single Centre Experience of Critically Ill Patients With Covid 19

NCT06821139Completed

Cohort Study of Intraoperative Lung Protective Ventilation Trends in a Large Canadian Health Authority

NCT06761612CompletedPrimary

Retail COVID-19 Study

NCT07597889Not ApplicableCompletedPrimary

Diagnostic Accuracy of 2 cm Versus 4 cm Insertion Depth for Nasal Swabs for SARS-CoV-2 (COVID-19) Rapid Antigen Testing-A Randomized Controlled Trial

NCT07302295Not ApplicableRecruiting

Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period

Scroll to load more

Research Network

Activity Timeline